2022 Revenues ($USD) : $1,014,600,000
2022 R&D spend : $61,300,000
2022 Number of Employees : 2,700
Fiscal Year End : 12/31/2021
Company CEO : Vafa Jamali, president and CEO

ZimVie became an independent public company on March 1, 2022, nearly 13 months after Zimmer Biomet announced it would spin off its spine and dental businesses. CEO Vafa Jamali earlier this year said there are opportunities for growth in the spine space, but the efforts could take years to accomplish. He pointed toward cervical disc replacement and pediatric scoliosis treatments as areas with growth potential. For now, the former Medtronic executive is focused on “some operational issues to fix within our spine business,” with ZimVie exiting several countries where the business had been unprofitable. –CN